xanthenes has been researched along with tolbutamide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldfine, ID; Perlman, R; Roth, J | 1 |
| Schöpf, E | 1 |
| Ichiki, H; Ishida, T; Iwamoto, N; Kato, M; Kubo, M; Miura, T; Okada, M; Sasaki, H; Seino, Y; Tanigawa, K | 1 |
| Gerich, FJ; Hepp, S; Müller, M | 1 |
4 other study(ies) available for xanthenes and tolbutamide
| Article | Year |
|---|---|
Inhibition of cyclic 3',5'-AMP phosphodiesterase in islet cells and other tissues by tolbutamide.
Topics: Adenoma, Islet Cell; Ammonium Sulfate; Animals; Brain; Cricetinae; Cyclic AMP; Hydrolysis; In Vitro Techniques; Insulin; Insulin Secretion; Kidney; Liver; Lung; Phosphoric Monoester Hydrolases; Sulfonylurea Compounds; Tolbutamide; Tritium; Xanthenes | 1971 |
[Important problems in allergy to chemically related drugs].
Topics: Aminosalicylic Acids; Amitriptyline; Anesthetics, Local; Anti-Bacterial Agents; Benzene Derivatives; Carbutamide; Dermatitis, Contact; Dibenzazepines; Drug Hypersensitivity; Furosemide; Humans; Parabens; Penicillins; Phenothiazines; Pyrazoles; Quinolines; Salicylates; Sulfonamides; Tolbutamide; Xanthenes | 1972 |
Antidiabetic activity of the rhizoma of Anemarrhena asphodeloides and active components, mangiferin and its glucoside.
Topics: Animals; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Mice; Phytotherapy; Plant Extracts; Plants, Medicinal; Tolbutamide; Xanthenes; Xanthones | 2001 |
Sulfhydryl oxidation reduces hippocampal susceptibility to hypoxia-induced spreading depression by activating BK channels.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Aniline Compounds; Animals; Calcium; Charybdotoxin; Cortical Spreading Depression; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamine; Hippocampus; Hypoxia; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Neurons; Nickel; Oxidation-Reduction; Patch-Clamp Techniques; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Rats; Rats, Sprague-Dawley; Sulfhydryl Reagents; Tolbutamide; Valine; Xanthenes | 2005 |